RecallHawk
Class II Recall

Brand Name: VITROS Product Name: VITROS 5600 Integrated System Model/Catalog Number: (1) 6802413, (2) 6802915

Ortho-Clinical Diagnostics, Inc.

Summary

The FDA issued a Class II for Brand Name: VITROS Product Name: VITROS 5600 Integrated System Model/Catalog N by Ortho-Clinical Diagnostics, Inc.. Reason: A software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the .

Details

Source

Device Recall

External ID

Z-2038-2025

Action Date

2025-07-09

Status

Ongoing

Category

device

Product Description

Brand Name: VITROS Product Name: VITROS 5600 Integrated System Model/Catalog Number: (1) 6802413, (2) 6802915

Lot/Code Info: VITROS 5600 Integrated System; Product Code: 6802413; UDI: 10758750002740; VITROS 5600 Integrated System - Certified/Refurbished; Product Code: 6802915; UDI: 10758750002740; Range of installed serial numbers: 56000143-56005096 Note1: The catalogue number 6802413 is used to denote the VITROS 5600 Integrated System. Catalogue number 6802915 is used to denote those VITROS 5600 Integrated Systems that have been refurbished, these systems can also be referred to as certified. A VITROS 5600 Integrated System maintains its original serial number through the refurbishment/certification process.

Quantity Affected: 3117 units (813 US, 2304 OUS)

Reason for Recall

A software anomaly allows test results to be reported using Micro Tip and Micro Slide diluent packs that the system treats as expired even when the Use Expired Reagents setting is not enabled if a shelf expiration date is omitted during manual loading. The issue was identified by a customer complaint, in which a CREA Urine test was processed with an RE (Reagent Expired) code, even though the diluent pack was not expired and the use-expired-reagents setting was disabled. This can result in erroneous test results and/or delaying test results.

Distribution

Worldwide Distribution: US (Nationwide) and OUS (International) to countries of: Australia, Belgium, Bermuda, Brazil, Canada, Chile, China, Colombia, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Singapore, Spain, Sweden, United Kingdom.

Type: Voluntary: Firm initiated

Recall Initiated: 2025-05-09

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 153 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Ortho-Clinical Diagnostics, Inc. has 71 FDA actions in our database, including 67 recalls and 4 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Ortho-Clinical Diagnostics, Inc.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Ortho-Clinical Diagnostics, Inc. have FDA actions?

Ortho-Clinical Diagnostics, Inc. has 71 FDA actions in our database, including 67 recalls and 4 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2038-2025" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions